Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early midlife ovarian removal is associated with lower posterior hippocampal function.
Brown A, Gravelsins L, Gervais NJ, Rieck J, Zhao S, Duchesne A, Witt ST, Kämpe R, Olsen R, Barense M, Classon E, Theodorsson E, Ernerudh J, Åvall-Lundqvist E, Kjølhede P, Engström M, Shao Z, Bernardini M, Jacobson M, Rajah MN, Grady C, Einstein G. Brown A, et al. Among authors: avall lundqvist e. Alzheimers Dement. 2024 Dec 28. doi: 10.1002/alz.14447. Online ahead of print. Alzheimers Dement. 2024. PMID: 39732509
Gray matter volume in women with the BRCA mutation with and without ovarian removal: evidence for increased risk of late-life Alzheimer's disease or dementia.
Witt ST, Brown A, Gravelsins L, Engström M, Classon E, Lykke N, Åvall-Lundqvist E, Theodorsson E, Ernerudh J, Kjölhede P, Einstein G. Witt ST, et al. Among authors: avall lundqvist e. Menopause. 2024 Jul 1;31(7):608-616. doi: 10.1097/GME.0000000000002361. Epub 2024 Apr 30. Menopause. 2024. PMID: 38688467
Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study.
Dahm-Kähler P, Rådestad AF, Holmberg E, Borgfeldt C, Bjurberg M, Sköld C, Hellman K, Kjølhede P, Stålberg K, Åvall-Lundqvist E. Dahm-Kähler P, et al. Among authors: avall lundqvist e. Gynecol Oncol. 2024 Jul;186:69-76. doi: 10.1016/j.ygyno.2024.03.011. Epub 2024 Apr 10. Gynecol Oncol. 2024. PMID: 38603954 Free article.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Roncolato F, King MT, O'Connell RL, Lee YC, Joly F, Hilpert F, Lanceley A, Yoshida Y, Bryce J, Donnellan P, Oza A, Avall-Lundqvist E, Berek JS, Ledermann JA, Berton D, Sehouli J, Kaminsky MC, Stockler MR, Friedlander M. Roncolato F, et al. Among authors: avall lundqvist e. Gynecol Oncol. 2024 Jun;185:128-137. doi: 10.1016/j.ygyno.2024.02.025. Epub 2024 Feb 26. Gynecol Oncol. 2024. PMID: 38412736 Free article.
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Campbell R, Costa DSJ, Stockler MR, Lee YC, Ledermann JA, Berton D, Sehouli J, Roncolato FT, Connell RO, Okamoto A, Bryce J, Oza AM, Avall-Lundqvist E, Berek JS, Lanceley A, Joly F, Hilpert F, Feeney A, Kaminsky MC, Diamante K, Friedlander ML, King MT; GCIG Symptom Benefit Group. Campbell R, et al. Among authors: avall lundqvist e. Gynecol Oncol. 2022 Aug;166(2):254-262. doi: 10.1016/j.ygyno.2022.05.024. Epub 2022 Jun 17. Gynecol Oncol. 2022. PMID: 35718565
Long-term incidence of endometrial cancer after endometrial resection and ablation: A population based Swedish gynecologic cancer group (SweGCG) study.
Flöter Rådestad A, Dahm-Kähler P, Holmberg E, Bjurberg M, Hellman K, Högberg T, Kjölhede P, Marcickiewicz J, Rosenberg P, Stålberg K, Åvall-Lundqvist E, Borgfeldt C. Flöter Rådestad A, et al. Among authors: avall lundqvist e. Acta Obstet Gynecol Scand. 2022 Aug;101(8):923-930. doi: 10.1111/aogs.14385. Epub 2022 May 27. Acta Obstet Gynecol Scand. 2022. PMID: 35624547 Free PMC article.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Lee YC, King MT, O'Connell RL, Lanceley A, Joly F, Hilpert F, Davis A, Roncolato FT, Okamoto A, Bryce J, Donnellan P, Oza AM, Avall-Lundqvist E, Berek JS, Ledermann JA, Berton D, Sehouli J, Feeney A, Kaminsky MC, Diamante K, Stockler MR, Friedlander ML; GCIG Symptom Benefit Group. Lee YC, et al. Among authors: avall lundqvist e. Int J Gynecol Cancer. 2022 Jun 6;32(6):761-768. doi: 10.1136/ijgc-2021-003142. Int J Gynecol Cancer. 2022. PMID: 35086926 Free PMC article.
114 results